相关实验视频

Updated: Jul 15, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

全癌症分析发现OAS1是多种瘤类型的潜在预后生物标志物

Shan Jiang¹, Xinzhou Deng^1,2, Ming Luo¹

¹Department of Clinical Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

Frontiers in oncology

|September 25, 2023

概括

这个2个2个2个2个

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
免疫学免疫学免疫学

背景情况:

2',5'-oligoadenylate synthetase 1 (OAS1) 被认为是乳腺癌和胰腺癌中的瘤驱动因素.
在各种癌症类型中OAS1的更广泛作用仍然在很大程度上未被探索.

研究的目的:

综合调查OAS1.1的泛癌表达,预后意义,诊断价值和免疫相关性.
在特定瘤模型中阐明OAS1对癌细胞行为的功能影响.

主要方法:

利用癌症基因组图集 (TCGA) 和人类蛋白质图集 (HPA) 数据库,在35种瘤类型中获取表达数据.
使用生物信息工具 (TIMER2,Kmplot,UALCAN,TISIDB) 进行癌分析.
在LUAD和PRAD细胞系上进行了体外细胞功能测定 (A549,H1975,PC-3,C4-2).

主要成果:

在35种瘤类型中,OAS1的表达有所不同,在12种瘤中有上调,在2种瘤中有下调.
高OAS1表达与6种瘤类型的预后不佳和2种瘤类型的预后良好相关.
OAS1显示与分子和免疫亚型,免疫检查点基因,瘤突变负担 (TMB) 的关联,并在15种瘤类型中具有潜在的诊断价值.
沉默OAS1抑制了增殖,诱导细胞循环停止,增强了细胞亡,并减少了LUAD和PRAD细胞的迁移.

结论:

OAS1作为一个潜在的泛癌分子生物标志物用于预后.
在各种癌症类型中,OAS1可能在瘤免疫反应中发挥重要作用.

关键词:

在OAS1中,OAS1是OAS1.生物标志物生物标志物胰腺癌是一种癌症.预后预后预后瘤免疫反应的免疫反应

更多相关视频

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...